The United States authorized Wednesday, September 22 the injection of a third dose of Pfizer's anti-Covid vaccine from the age of 65 and for people at
, announced the United States Medicines Agency.
Covid-19: the third vaccine dose, instructions for use
Read alsoA 3rd dose of vaccine for all Americans?
Experts invited to decide
The booster dose can be administered from six months after the second injection.
Before age 65, those eligible for this booster dose include those at
of developing a severe form of the disease, as well as those
"whose frequent exposure"
to the virus puts them in a
serious complications ”
related to the disease, according to a press release from the US agency (FDA).
This decision includes
"health workers, teachers and school staff, workers in supermarkets and those in homeless shelters or prisons, and others,"
said acting chief of the FDA, Janet. Woodcock, cited in press release.
If the categories of the population concerned therefore appear broad, this decision is nevertheless a setback for the administration of President Joe Biden, who announced in mid-August that the reminders could be administered to all American adults.
The government has since been widely criticized for appearing to anticipate the decision of the scientific authorities, and has been accused of causing confusion.
The FDA ultimately chose to follow the advice of its advisory committee.
The latter, made up in particular of epidemiologists and infectious disease specialists, spoke out last week to limit the injection of a booster to certain categories of populations, in particular the elderly and health personnel.
Read alsoCovid-19: the third vaccine dose, instructions for use
A committee of experts from the Centers for Disease Prevention and Control (CDC) was also meeting on Wednesday and Thursday to discuss the issue in turn.
The health authorities must then publish detailed recommendations intended for professionals supposed to administer these third doses, which must in particular specify what is covered by the term “high risk”.